{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:49:25Z","timestamp":1783694965299,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12954-016-0112-3","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T08:21:48Z","timestamp":1467620508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of combination approach on harm reduction programs: the Taiwan experience"],"prefix":"10.1186","volume":"13","author":[{"given":"Ting","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hsun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pesus","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,4]]},"reference":[{"key":"112_CR1","volume-title":"The global state of harm reduction 2008: mapping the response to drug-related HIV and hepatitis C epidemics","author":"C Cook","year":"2008","unstructured":"Cook C, Kanaef N. The global state of harm reduction 2008: mapping the response to drug-related HIV and hepatitis C epidemics. London: Harm Reduction International; 2008."},{"key":"112_CR2","doi-asserted-by":"publisher","unstructured":"Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008, DOI: 10.1016\/S0140-6736(08)61311-2 .","DOI":"10.1016\/S0140-6736(08)61311-2"},{"issue":"Suppl 1","key":"112_CR3","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/QAI.0b013e3181f9c0c9","volume":"55","author":"C Beyer","year":"2010","unstructured":"Beyer C, Wirtz AL, Baral S, Peryskina A, Sifakis F. Epidemiologic links between drug use and HIV epidemics: an international perspective. J Acquir Immune Defic Syndr. 2010;55 Suppl 1:S10\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"112_CR4","doi-asserted-by":"crossref","unstructured":"Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, et al. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLOS Med. 2014; 11(6): http:\/\/dx.doi.org\/10.1371\/journal.pmed.1001663 , Accessed March 05, 2015.","DOI":"10.1371\/journal.pmed.1001663"},{"key":"112_CR5","doi-asserted-by":"crossref","DOI":"10.18356\/b07f5d3f-en","volume-title":"World drug report 2015","author":"UNODC","year":"2015","unstructured":"UNODC. World drug report 2015. Vienna: United Nations Office on Drugs and Crime; 2015."},{"key":"112_CR6","unstructured":"World Health Organization, United Nations Office on Drugs and Crime, Joint United Nations Program on HIV\/AIDS.HO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users: 2012 revision."},{"issue":"Suppl 1","key":"112_CR7","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/QAI.0b013e3181f9c203","volume":"55","author":"BDL Marshall","year":"2010","unstructured":"Marshall BDL, Wood E. Toward a comprehensive approach to HIV prevention for people who use drugs. J Acquir Immune Defic Syndr. 2010;55 Suppl 1:S23\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"112_CR8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0140-6736(10)60928-2","volume":"376","author":"C Beyrer","year":"2010","unstructured":"Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, et al. Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet. 2010;376:551\u201363. http:\/\/dx.doi.org\/10.1016\/S0140-6736(10)60928-2 .","journal-title":"Lancet"},{"key":"112_CR9","volume-title":"The case for a harm reduction decade: progress, potential and paradigm shifts","author":"C Cook","year":"2016","unstructured":"Cook C, Phelan M, Sander G, Stone K, Murphy F. The case for a harm reduction decade: progress, potential and paradigm shifts. London: Harm Reduction International; 2016."},{"key":"112_CR10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","volume":"376","author":"L Degenhardt","year":"2010","unstructured":"Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, et al. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376:285\u2013301. http:\/\/dx.doi.org\/10.1016\/S0140-6736(10)60742-8 .","journal-title":"Lancet"},{"key":"112_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1473-3099(12)70273-6","volume":"13","author":"IW Chang","year":"2013","unstructured":"Chang IW, Serwadda D, Quinn TC, Wawer MJ, Gray RH, et al. Combination implementation for HIV prevention: move from clinical trial evidence to population-level effects. Lancet Infect Dis. 2013;13:65\u201376. doi: 10.1016\/S1473-3099(12)70273-6 .","journal-title":"Lancet Infect Dis"},{"key":"112_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11904-010-0063-3","volume":"8","author":"AE Kurth","year":"2011","unstructured":"Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN. Combination HIV prevention: significance, challenges, and opportunity. Curr HIV\/AIDS Rep. 2011;8:62\u201372. doi: 10.1007\/s11904-010-0063-3 .","journal-title":"Curr HIV\/AIDS Rep"},{"key":"112_CR13","unstructured":"Taiwan Centers for Disease Control, Department of Health Executive Yuan. [HIV\/AIDS statistics 2012, 2015] Available: http:\/\/www.cdc.gov.tw\/professional\/info.aspx?treeid=BEAC9C103DF952C4&nowtreeid=2F13020F8A921CCB&tid=5250BA9AD485D6C3 , Accessed March 01, 2013. http:\/\/www.cdc.gov.tw\/professional\/info.aspx?treeid=7B56E6F932B49B90&nowtreeid=2F13020F8A921CCB&tid=97D39D2BB81D32E9 , Accessed 30 May 2016."},{"key":"112_CR14","unstructured":"Taiwan Food and Drug Administration, Ministry of Health and Welfare. Statistics of urine drug tests and statistics of indiscriminate use from the reporting system in Taiwan psychiatric hospitals, Available: http:\/\/www.fda.gov.tw\/TC\/site.aspx?sid=1578 , Accessed 30 May 2016."},{"key":"112_CR15","unstructured":"Taiwan Ministry of Health and Welfare, Ministry of Justice, Ministry of Education, Ministry of Foreign Affairs: anti-drug report 2014, 2012, 2010, 2008, Taipei, Ministry of Health and Welfare, Ministry of Justice, Ministry of Education, Ministry of Foreign Affairs, 2014, 2012, 2010, 2008. Available: http:\/\/enc.moe.edu.tw\/UploadFile\/eBook\/20141106222602302347\/flipbook.html #, Accessed 30 May 2016."},{"key":"112_CR16","unstructured":"Taiwan Centers for Disease Control, Department of Health Executive Yuan. [Harm Reduction Programs statistics, NSPs, 2012, 2015] Available: http:\/\/www.cdc.gov.tw\/professional\/list.aspx?treeid=BEAC9C103DF952C4&nowtreeid=981AAD792FA60FD4 . Accessed 1 March 2013. http:\/\/www.cdc.gov.tw\/professional\/page.aspx?treeid=7B56E6F932B49B90&nowtreeid=F8DAA50F9AC2C146 , Accessed 5 March 2016."},{"key":"112_CR17","unstructured":"Taiwan Centers for Disease Control, Department of Health Executive Yuan. [Harm Reduction Programs statistics, OST program, 2012]. Available: http:\/\/www.cdc.gov.tw\/PROFESSIONAL\/info.aspx?treeid=BEAC9C103DF952C4&nowtreeid=0BAD99D4B913EDCA&tid=495BB8FA3879F85A , Accessed 1 March 2013."},{"key":"112_CR18","unstructured":"Taiwan Ministry of Health and Welfare. [Addiction Treatment, OST program, 2015]. Available: http:\/\/www.mohw.gov.tw\/CHT\/DOMHAOH\/DM1.aspx?f_list_no=184&fod_list_no=4166 , Accessed 5 March 2016."},{"key":"112_CR19","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S0140-6736(11)60786-1","volume":"379","author":"SY Lyu","year":"2012","unstructured":"Lyu SY, Su LW, Chen Arthur YM. Effects of education on harm-reduction programmes. Lancet. 2012;379:e28\u201330. Published Online: 17 Aug 2011, http:\/\/dx.doi.org\/10.1016\/S0140-6736(11)60786-1 .","journal-title":"Lancet"},{"key":"112_CR20","doi-asserted-by":"crossref","unstructured":"Rich JD, McKenzie M, Larney S, Wong JB, Tran L, et al. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet 2015. Published online, http:\/\/dx.doi.org\/10.1016\/S0140-6736(14)62338-2 .","DOI":"10.1016\/S0140-6736(14)62338-2"},{"key":"112_CR21","doi-asserted-by":"crossref","unstructured":"Milloy MJ, Wood E. Withdrawal from methadone in US prisons: cruel and unusual? Lancet 2015. Published online http:\/\/dx.doi.org\/10.1016\/S0140-6736(15)60073\u20133 .","DOI":"10.1016\/S0140-6736(15)60073-3"},{"key":"112_CR22","doi-asserted-by":"crossref","unstructured":"Huang YF, Yang JY, Nelson KE, Kuo HS, Lew Ting CY, et al. Changes in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: a study of two cohorts. PLOS Med. 2014; 11(4). http:\/\/dx.doi.org\/10.1371\/journal.pmed.1001625 , Accessed May 30, 2016.","DOI":"10.1371\/journal.pmed.1001625"},{"issue":"6","key":"112_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2105\/AJPH.2008.141846","volume":"99","author":"L Wiessing","year":"2009","unstructured":"Wiessing L, Likatavicius G, Klempova D, Hedrich D, Nardone A, et al. Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users. Am J Public Health. 2009;99(6):1049\u201352. doi: 10.2105\/AJPH.2008.141846 .","journal-title":"Am J Public Health"},{"issue":"9","key":"112_CR24","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","volume":"102","author":"C Berg Van Den","year":"2007","unstructured":"Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M. Full participation in harm reduction programs is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam cohort studies among drug users. Addiction. 2007;102(9):1454\u201362. doi: 10.1111\/j.1360-0443.2007.01912.x .","journal-title":"Addiction"},{"key":"112_CR25","unstructured":"World Health Organization, Western Pacific Regional Office, World Health Organization Office of the Representative for Brunei Darussalam, Malaysia and Singapore, Ministry of Health Malaysia. Good practices in Asia: effective paradigm shifts towards an improved national response to drugs and HIV\/AIDS: scale-up of harm reduction in Malaysia. Manila, World Health Organization, Western Pacific Region, 2011."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-016-0112-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:46:11Z","timestamp":1498311971000},"score":1,"resource":{"primary":{"URL":"http:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-016-0112-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,4]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["112"],"URL":"https:\/\/doi.org\/10.1186\/s12954-016-0112-3","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,4]]},"article-number":"23"}}